GPX4 and renal cell carcinoma: Additionally, it is imperative for future investigations to incorporate prospective data from renal cell carcinoma (RCC) patients and conduct in vitro experiments to validate the impact of SLC7A11 or GPX4 on the malignant biological behavior of RCC cells, thereby reinforcing the findings presented in this study.